Human immunodeficiency virus type 1 clade A and D neurotropism: Molecular evolution, recombination, and coreceptor use

Virology

Volumn 283, Issue 1, 2001, Pages 19-30

  Zhang, Kunyan ^a   Hawken, Mark ^b   Rana, Farazana ^c   Welte, Frank J ^d   Gartner, Suzanne ^e   Goldsmith, Mark A ^d   Power, Christopher ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c UNIVERSITY OF NAIROBI   (Kenya)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR5; VIRUS RECEPTOR;

ARTICLE; CHIMERA; CLONE; FEMALE; GENE CLUSTER; GENE SEQUENCE; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MALE; MOLECULAR EVOLUTION; NEUROTROPISM; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL; VIRUS RECOMBINATION;

EID: 0035946307     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2001.0876     Document Type: Article

References (67)

1. CC CKR5: A RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1
2. Host-specific modulation of the selective constraints driving human immunodeficiency virus type 1 env gene evolution
3. HIV-1 subtypes in Nairobi, Kenya
4. Full-length sequence and mosaic structure of a human immunodeficiency virus type 1 isolate from Thailand
5. V3 recombinants indicate a central role for CCR5 as a coreceptor in tissue infection by human immunodeficiency virus type 1
6. Macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates. Definition of critical amino acids involved in cell tropism
7. Mapping of independent V3 envelope determinants of human immunodeficiency virus type 1 macrophage tropism and syncytium formation in lymphocytes
8. The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates
9. The V3 domain of the HIV-1 gp120 envelope glycoprotein is critical for chemokine-mediated blockade of infection
10. Human immunodeficiency virus type 1 subtypes defined by env show high frequency of recombinant gag genes: The UNAIDS Network for HIV Isolation and Characterization
11. Disease progression and survival in HIV-1-infected Africans in London
12. Identification of a major coreceptor for primary isolates of HIV-1
13. A dual-tropic primary HIV-1 isolate that uses fusin and the beta- chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors
14. + cells is mediated by the chemokine receptor CC-CKR-5
15. HIV-1 V3 domain variation in brain and spleen of children with AIDS. Tissue-specific evolution within host-determined quasispecies
16. Molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G: The WHO and NIAID Networks for HIV Isolation and Characterization
17. The heterosexual human immunodeficiency virus type 1 epidernic in Thailand is caused by an intersubtype (A/E) recombinant of African origin
18. Gp120 sequence variation in brain and in T-lymphocyte human immunodeficiency virus type 1 primary isolates
19. Relation of phenotype evolution of HIV-1 to envelope V2 configuration
20. Genetic consequences of packaging two RNA genomes in one retroviral particle: Pseudodiploidy and high rate of genetic recombination
21. Investigation of the dynamics of the spread of human immunodeficiency virus to brain and other tissues by evolutionary analysis of sequences from the p17gag and env genes
22. Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1
23. Human immunodeficiency virus type 1 subtypes differ in disease progression
24. Generation of diversity in retroviruses
25. Genetic differences between blood- and brain-derived viral sequences from human immunodeficiency virus type 1-infected patients: Evidence of conserved elements in the V3 region of the envelope protein of brain-derived sequences
26. Differences in human immunodeficiency virus type 1 V3 sequences from patients with and without AIDS dementia complex
27. Biological and molecular characterization of subtype D, G, and A/D recombinant HIV-1 transmissions in Sweden
28. Molecular characterization of human immunodeficiency virus type 1 cloned directly from uncultured human brain tissue: Identification of replication-competent and -defective viral genomes
29. Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination
30. Patterns of HIV-1 evolution in individuals with differing rates of CD4 T cell decline
31. HIV-1 tat molecular diversity and induction of TNF-alpha: Implications for HIV-induced neurological disease
32. Diversity of the envelope glycoprotein among human immunodeficiency virus type 1 isolates of clade E from Asia and Africa
33. HIV-1 genetic diversity
34. Patterns of amino acid variability in NSI-like and SI-like V3 sequences and a linked change in the CD4-binding domain of the HIV-1 Env protein
35. High resolution analysis of HIV-1 quasispecies in the brain
36. Mosaic structure of the human immunodeficiency virus type 1 genome infecting lymphoid cells and the brain. Evidence for frequent in vivo recombination events in the evolution of regional populations
37. Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions
38. Subtypes of human immunodeficiency virus type 1 and disease stage among women in Nairobi, Kenya
39. Antigenic diversity thresholds and the development of AIDS
40. + lymphocyte counts and the risk of progression to AIDS: Veterans Affairs Cooperative Study Group on AIDS
41. Apoptosis induced by infection of primary brain cultures with diverse human immunodeficiency virus type 1 isolates: Evidence for a role of the envelope
42. Alterations in potential sites for glycosylation predominate during evolution of the simian immunodeficiency virus envelope gene in macaques
43. HIV-1 env sequence variation in brain tissue of patients with AIDS-related neurologic disease
44. Characterization of V3 sequence heterogeneity in subtype C human immunodeficiency virus type 1 isolates from Malawi: Underrepresentation of X4 variants
45. Variants from the diverse virus population identified at seroconversion of a clade A human immunodeficiency virus type 1-infected woman have distinct biological properties
46. Distinct HIV-1 env sequences are associated with neurotropism and neurovirulence
47. Demented and nondemented patients with AIDS differ in brain-derived human immunodeficiency virus type 1 envelope sequences
48. Neuronal death induced by brain-derived human immunodeficiency virus type 1 envelope genes differs between demented and nondemented AIDS patients
49. Autopsy study of HIV-1-positive and HIV-1-negative adult medical patients in Nairobi, Kenya
50. Sequence analysis of the V3 loop in brain and spleen of patients with HIV encephalitis
51. Recombination in AIDS viruses
52. Recombination in HIV-1
53. Current estimates of and future projections for adult deaths attributed to HIV infection in Zimbabwe
54. Evolution and probable transmission of intersubtype recombinant human immunodeficiency virus type 1 in a Zambian couple
55. Analyzing the mosaic structure of genes
56. Selective employment of chemokine receptors as human immunodeficiency virus type 1 co-receptors determined by individual amino acids within the envelope V3 loop
57. Natural history of human immunodeficiency virus type 1 infection in children: A five-year prospective study in Rwanda
58. Immunologic principles related to the nervous system and the eye: Concerning the existence of a neural-ocular immune system
59. Human immunodeficiency virus type 1 intergroup (M/O) recombination in cameroon
60. Impact of the HIV epidemic on mortality in sub-Saharan Africa: Evidence from national surveys and censuses
61. Hypervariable region 3 residues of HIV type 1 gp120 involved in CCR5 coreceptor utilization: Therapeutic and prophylactic implications
62. Macrophage tropism determinants of human immunodeficiency virus type 1 in vivo
63. Adaptive evolution of human immunodeficiency virus-type 1 during the natural course of infection
64. In vivo compartmentalization of human immunodeficiency virus: Evidence from the examination of pol sequences from autopsy tissues